Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I SAD/MAD study of CH-4051 in healthy male volunteers
NL-OMON32763Active, not recruiting
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Oct 2008
- Countries
- 1
01
Overview
Trial, sponsored by Chelsea Therapeutics International, Ltd. Started Oct 2008; status: active, not recruiting.
Beyond the preview
Go deeper on NL-OMON32763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32763.